Massachusetts Financial Services Co. MA Sells 1,000,059 Shares of Masimo Co. (NASDAQ:MASI)

Massachusetts Financial Services Co. MA cut its stake in shares of Masimo Co. (NASDAQ:MASI) by 58.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 721,726 shares of the medical equipment provider’s stock after selling 1,000,059 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 1.36% of Masimo worth $90,894,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in Masimo by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 4,781,343 shares of the medical equipment provider’s stock worth $560,421,000 after purchasing an additional 26,473 shares during the period. Capital Research Global Investors raised its position in Masimo by 6.4% during the fourth quarter. Capital Research Global Investors now owns 2,269,189 shares of the medical equipment provider’s stock valued at $265,972,000 after purchasing an additional 136,617 shares during the period. Farallon Capital Management LLC raised its holdings in shares of Masimo by 13.6% in the first quarter. Farallon Capital Management LLC now owns 1,489,563 shares of the medical equipment provider’s stock worth $218,742,000 after buying an additional 177,914 shares during the period. Schroder Investment Management Group raised its holdings in shares of Masimo by 59.6% in the fourth quarter. Schroder Investment Management Group now owns 877,539 shares of the medical equipment provider’s stock worth $102,856,000 after buying an additional 327,863 shares during the period. Finally, Westfield Capital Management Co. LP raised its holdings in shares of Masimo by 35.6% in the fourth quarter. Westfield Capital Management Co. LP now owns 818,476 shares of the medical equipment provider’s stock worth $95,934,000 after buying an additional 214,795 shares during the period. 85.96% of the stock is currently owned by institutional investors.

Masimo Trading Down 0.6 %

MASI opened at $114.31 on Thursday. Masimo Co. has a one year low of $75.22 and a one year high of $153.93. The stock has a market capitalization of $6.08 billion, a PE ratio of 77.76 and a beta of 0.98. The business’s 50 day moving average price is $114.81 and its 200 day moving average price is $125.17. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.15 and a current ratio of 2.09.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share for the quarter, topping analysts’ consensus estimates of $0.77 by $0.09. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The business had revenue of $496.30 million for the quarter, compared to analyst estimates of $493.92 million. During the same quarter in the prior year, the company earned $0.62 earnings per share. The company’s revenue was up 9.0% on a year-over-year basis. As a group, equities research analysts expect that Masimo Co. will post 3.87 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have commented on MASI shares. Piper Sandler raised their price objective on Masimo from $160.00 to $165.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research report on Wednesday, August 7th. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $144.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.